Neuralink technology connecting brain to the computer – Tesla CEO Elon Musk

Neuralink technology is concerned with implanting electrodes in the brain of humans through ‘ultra-thin threads’. These will be connected through the chip and shreds in the skin of the human mind. These chips will be connected to removable pods that will be fitted behind the ears and connected to another device without wires. Through this, the information inside the brain will be recorded directly on the smartphone or computer.

This chip will be connected to thousands of microscopic threads. Musk claimed that with the help of this brain-computer interface technology, many types of neurological diseases can be easily treated. Also, this device will prove to be a boon for the treatment of paralysis and spinal cord injury.

Key Features:

  • No longer headphones would be required, with this technology.
  • Music will reach to the brain with a smart chip.
  • It will also help humans to fight from depression.
  • The chip will be ten times thinner than hair.
  • The chip will connect behind the ear.
  • Will be able to take information on the smartphone.
  • This device will prove to be a boon for the treatment of paralysis and spinal cord injury.
Neuralink technology
Image Source:www.economist.com/

If the Neuralink Brain Implant technology of Tesla CEO Elon Musk, one of the world’s famous tech company succeeds, then the world will cease to be such a headphone. Elon Musk is funding a project called Neuralink, a computer is being built under it, which will be equivalent to a small chip.

During a conversation, Musk claimed that this one-inch chip could be performed by surgery that the device made by the company could be music. Musk is planning to launch this device soon.

Elon Musk launched a project called Neuralink in 2016. Under this, extremely thin and flexible shreds are thinly designed and implanted directly in mind.

Also, this technique can be used to improve the lives of people suffering from diseases like Alzheimer’s and Parkinson’s. Its human trials are in the final stages after successful testing on monkeys and mice.